Stephen B. Shohet, Director at Amphastar Pharmaceuticals, Inc. (AMPH), sold 7,862 shares at $18.39 ($145K) on 2017-10-26, disclosed to the SEC on 2017-10-26.
Scheduled sale ($145k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AMPH | SELL | 2017-12-08 | $144K | — | Filing → |
| AMPH | SELL | 2017-11-30 | $151K | — | Filing → |
| AMPH | SELL | 2017-11-24 | $149K | — | Filing → |